DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 884 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,095,618 | -5.7% | 4,347 | -0.7% | 0.05% | -11.5% |
Q4 2022 | $1,161,478 | -6.6% | 4,376 | -9.1% | 0.05% | -16.1% |
Q3 2022 | $1,244,000 | +1.5% | 4,816 | -0.4% | 0.06% | +5.1% |
Q2 2022 | $1,226,000 | -14.3% | 4,834 | -0.8% | 0.06% | -3.3% |
Q1 2022 | $1,430,000 | +19.2% | 4,874 | +33.7% | 0.06% | +22.0% |
Q4 2021 | $1,200,000 | +3.1% | 3,646 | -6.2% | 0.05% | 0.0% |
Q3 2021 | $1,164,000 | +17.1% | 3,889 | +5.0% | 0.05% | +6.4% |
Q2 2021 | $994,000 | +18.1% | 3,704 | -1.0% | 0.05% | +9.3% |
Q1 2021 | $842,000 | +10.2% | 3,742 | +8.7% | 0.04% | +4.9% |
Q4 2020 | $764,000 | +1.7% | 3,441 | -1.3% | 0.04% | -10.9% |
Q3 2020 | $751,000 | +23.9% | 3,486 | +1.8% | 0.05% | +17.9% |
Q2 2020 | $606,000 | +27.8% | 3,426 | 0.0% | 0.04% | +8.3% |
Q1 2020 | $474,000 | -9.9% | 3,426 | 0.0% | 0.04% | +16.1% |
Q4 2019 | $526,000 | -11.3% | 3,426 | -16.6% | 0.03% | -16.2% |
Q3 2019 | $593,000 | -3.7% | 4,108 | -4.6% | 0.04% | -2.6% |
Q2 2019 | $616,000 | -61.4% | 4,308 | -64.3% | 0.04% | -62.4% |
Q1 2019 | $1,594,000 | +13.9% | 12,077 | -10.9% | 0.10% | 0.0% |
Q4 2018 | $1,399,000 | -8.6% | 13,562 | -3.7% | 0.10% | +4.1% |
Q3 2018 | $1,531,000 | +9.8% | 14,089 | -0.3% | 0.10% | +3.2% |
Q2 2018 | $1,394,000 | +0.9% | 14,127 | +0.1% | 0.09% | 0.0% |
Q1 2018 | $1,381,000 | -0.9% | 14,109 | -6.1% | 0.09% | -1.1% |
Q4 2017 | $1,394,000 | +6.2% | 15,019 | -1.8% | 0.10% | 0.0% |
Q3 2017 | $1,312,000 | +3.6% | 15,299 | +2.0% | 0.10% | -5.0% |
Q2 2017 | $1,266,000 | -4.9% | 14,999 | -3.6% | 0.10% | -9.9% |
Q1 2017 | $1,331,000 | +2.9% | 15,559 | -6.4% | 0.11% | -1.8% |
Q4 2016 | $1,294,000 | -0.9% | 16,618 | -0.3% | 0.11% | -4.2% |
Q3 2016 | $1,306,000 | -18.7% | 16,663 | +4.8% | 0.12% | -23.4% |
Q2 2016 | $1,606,000 | +2.2% | 15,904 | -4.0% | 0.15% | -1.3% |
Q1 2016 | $1,572,000 | -51.9% | 16,569 | -52.9% | 0.16% | -54.0% |
Q4 2015 | $3,269,000 | +33.2% | 35,198 | +22.2% | 0.34% | +27.0% |
Q3 2015 | $2,455,000 | +63.0% | 28,810 | +63.7% | 0.27% | +76.8% |
Q2 2015 | $1,506,000 | +45.2% | 17,600 | +44.1% | 0.15% | +43.8% |
Q1 2015 | $1,037,000 | +35.9% | 12,212 | +37.2% | 0.10% | +31.2% |
Q4 2014 | $763,000 | +47.6% | 8,902 | +30.8% | 0.08% | +40.4% |
Q3 2014 | $517,000 | +36.4% | 6,808 | +41.6% | 0.06% | +39.0% |
Q2 2014 | $379,000 | +75.5% | 4,808 | +67.1% | 0.04% | +70.8% |
Q1 2014 | $216,000 | -2.7% | 2,878 | 0.0% | 0.02% | -7.7% |
Q4 2013 | $222,000 | – | 2,878 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |